Cardiovascular Diseases Research in South Carolina
Cardiovascular Diseases Research (93.837) awarded $81.4 million to recipients in South Carolina in 95 grants from fiscal 2021 to 2025, 0.5% of the program's national total. The Medical University of South Carolina received the most, $42.5 million.
- Awarded in South Carolina$81.4 million
- Awards95
- Share of the program0.5%
- Rank among states31st of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 40 | $14.3 million |
| FY 2022 | 40 | $15.7 million |
| FY 2023 | 40 | $16.1 million |
| FY 2024 | 46 | $17.0 million |
| FY 2025 | 40 | $18.4 million |
Recipients in South Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Medical University of South Carolina | Colleges and universities | 49 | $42.5 million |
| University of South Carolina | Colleges and universities | 18 | $21.8 million |
| Clemson University | Colleges and universities | 16 | $10.7 million |
| Tissue Testing Technologies LLC | Small businesses | 3 | $2.6 million |
| Obsidio Inc | Small businesses | 1 | $1.4 million |
| Fibrotherapeutics Inc | Small businesses | 2 | $606,402 |
| Aptus, LLC | Small businesses | 2 | $573,806 |
| Thendor Therapeutics Inc | Small businesses | 1 | $389,754 |
| Lucie Medical Inc | Small businesses | 1 | $308,526 |
| Acepre, LLC | Small businesses | 1 | $299,953 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to South Carolina?
$81.4 million from fiscal 2021 to 2025, across 95 awards. South Carolina ranks 31st of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in South Carolina?
The largest recipient is The Medical University of South Carolina, with $42.5 million in 49 awards. Next are University of South Carolina and Clemson University.
Can organizations in South Carolina apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in South Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start